 |
|
Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
Rachael Z. Stolzenberg-Solomon, PhD;
Barry I. Graubard, PhD;
Suresh Chari, MD;
Paul Limburg, MD;
Philip R. Taylor, MD, ScD;
Jarmo Virtamo, MD;
Demetrius Albanes, MD
JAMA. 2005;294:2872-2878.
Context Obesity, diabetes mellitus, and glucose intolerance have been associated with increased pancreatic cancer risk; however, prediagnostic serum insulin concentration has not been evaluated as a predictor of this malignancy.
Objective To investigate whether prediagnostic fasting glucose and insulin concentrations and insulin resistance are associated with subsequent incidence of exocrine pancreatic cancer in a cohort of male smokers.
Design, Setting, and Participants A case-cohort prospective study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (1985-1988) cohort of 29 133 male Finnish smokers ages 50 to 69 years. The study included 400 randomly sampled subcohort control participants and 169 incident pancreatic cancer cases that occurred after the fifth year of follow-up. All participants were followed up through December 2001 (up to 16.7 years of follow-up).
Main Outcome Measures Incident exocrine pancreatic cancer identified from the Finnish Cancer Registry.
Results After adjusting for age, smoking, and body mass index, higher baseline fasting serum concentrations of glucose, insulin, and insulin resistance were positively associated with pancreatic cancer. The presence of biochemically defined diabetes mellitus (glucose,  126 mg/dL [6.99 mmol/L]) and insulin concentration in the highest vs lowest quartile both showed a significant 2-fold increased risk (hazard ratio [HR], 2.13; 95% confidence interval [CI], 1.04-4.35; and HR, 2.01; 95% CI, 1.03-3.93; respectively). There were significant interactions for all the biomarker exposures by follow-up time, such that the positive associations were stronger among the cases that occurred more than 10 years after baseline (highest vs lowest quartile: glucose, HR, 2.16; 95% CI, 1.05-4.42; P for trend = .02; insulin, HR, 2.90; 95% CI, 1.22-6.92; P for trend = .005; and insulin resistance, HR, 2.71; 95% CI, 1.19-6.18; P for trend = .006).
Conclusions These results support the hypothesis that exposure to higher insulin concentrations and insulin resistance predicts the risk of exocrine pancreatic cancer.
Author Affiliations: Nutritional Epidemiology Branch (Drs Stolzenberg-Solomon and Albanes), Biostatistics Branch (Dr Graubard), and Genetic Epidemiology Branch (Dr Taylor), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Rockville, Md; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minn (Drs Chari and Limburg); and Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland (Dr Virtamo).
RELATED ARTICLE
Pancreatic Cancer
Erin Brender, Alison Burke, and Richard M. Glass
JAMA. 2005;294(22):2934.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study
Bao et al.
Am. J. Clin. Nutr. 2008;88:431-440.
ABSTRACT
| FULL TEXT
Glycemic load, glycemic index, and pancreatic cancer risk in the Netherlands Cohort Study
Heinen et al.
Am. J. Clin. Nutr. 2008;87:970-977.
ABSTRACT
| FULL TEXT
Adiposity, Physical Activity, and Pancreatic Cancer in the National Institutes of Health-AARP Diet and Health Cohort
Stolzenberg-Solomon et al.
Am J Epidemiol 2008;167:586-597.
ABSTRACT
| FULL TEXT
Pancreatic Cancer and Factors Associated with the Insulin Resistance Syndrome in the Korean Cancer Prevention Study
Berrington de Gonzalez et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:359-364.
ABSTRACT
| FULL TEXT
Obesity and cancer
Calle
BMJ 2007;335:1107-1108.
FULL TEXT
Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study
Nothlings et al.
Am. J. Clin. Nutr. 2007;86:1495-1501.
ABSTRACT
| FULL TEXT
Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women
Michaud et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2101-2109.
ABSTRACT
| FULL TEXT
Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer
Wolpin et al.
Cancer Res. 2007;67:7923-7928.
ABSTRACT
| FULL TEXT
Anthropometry and Pancreatic Cancer Risk: An Illustration of the Importance of Microscopic Verification
Verhage et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1449-1454.
ABSTRACT
| FULL TEXT
Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973 2002
Zhang et al.
Ann Oncol 2007;18:1268-1279.
ABSTRACT
| FULL TEXT
A Prospective Study of Periodontal Disease and Pancreatic Cancer in US Male Health Professionals
Michaud et al.
JNCI J Natl Cancer Inst 2007;99:171-175.
ABSTRACT
| FULL TEXT
Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study.
Larsson et al.
Am. J. Clin. Nutr. 2006;84:1171-1176.
ABSTRACT
| FULL TEXT
A Prospective Nested Case-Control Study of Vitamin D Status and Pancreatic Cancer Risk in Male Smokers
Stolzenberg-Solomon et al.
Cancer Res. 2006;66:10213-10219.
ABSTRACT
| FULL TEXT
Third Annual World Congress on the Insulin Resistance Syndrome: Associated conditions.
Bloomgarden
Diabetes Care 2006;29:2165-2174.
FULL TEXT
18F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study
Iozzo et al.
JNM 2006;47:1016-1022.
ABSTRACT
| FULL TEXT
Genetics and biology of pancreatic ductal adenocarcinoma.
Hezel et al.
Genes Dev. 2006;20:1218-1249.
ABSTRACT
| FULL TEXT
Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition.
Berrington de Gonzalez et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:879-885.
ABSTRACT
| FULL TEXT
|
